Loading…

First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022

Abstract STUDY QUESTION What is the estimated prevalence and incidence of uterine fibroids diagnosed in Australian women of reproductive age? SUMMARY ANSWER An estimated 7.3% of Australian women had a diagnosis of uterine fibroids by the age of 45–49 years, with age-specific incidence highest in wom...

Full description

Saved in:
Bibliographic Details
Published in:Human reproduction (Oxford) 2024-09, Vol.39 (9), p.2134-2143
Main Authors: Wilson, L F, Moss, K M, Doust, J, Farquhar, C M, Mishra, G D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c310t-901dd8ec23268ece6c6b8f899c3d2683da83aef9c54a92409653f3edc6c5f1263
container_end_page 2143
container_issue 9
container_start_page 2134
container_title Human reproduction (Oxford)
container_volume 39
creator Wilson, L F
Moss, K M
Doust, J
Farquhar, C M
Mishra, G D
description Abstract STUDY QUESTION What is the estimated prevalence and incidence of uterine fibroids diagnosed in Australian women of reproductive age? SUMMARY ANSWER An estimated 7.3% of Australian women had a diagnosis of uterine fibroids by the age of 45–49 years, with age-specific incidence highest in women aged 40–44 years (5.0 cases per 1000 person-years). WHAT IS KNOWN ALREADY Uterine fibroids are associated with a high symptom burden and may affect overall health and quality of life. Studies in different countries show a wide variation in both the prevalence (4.5–68%) and incidence (2.2–37.5 per 1000 person-years) of uterine fibroids, which may be partly explained by the type of investigation, method of case ascertainment, or the age range of the study population, necessitating the reporting of country-specific estimates. STUDY DESIGN, SIZE, DURATION This observational prospective cohort study using self-report survey and linked administrative data (2000–2022) included 8066 women, born between 1973 and 1978, in the Australian Longitudinal Study on Women’s Health. PARTICIPANTS/MATERIALS, SETTING, METHODS A combination of self-report survey and linked administrative health data (hospital, emergency department, the Medicare Benefits Schedule, and the Pharmaceutical Benefits Scheme) were used to identify women with a report of a diagnosis of uterine fibroids between 2000 and 2022. MAIN RESULTS AND THE ROLE OF CHANCE Of the 8066 Australian women followed for 22 years, an estimated 7.3% of women (95% CI 6.9, 7.6) had a diagnosis of uterine fibroids by the age of 45–49 years. The incidence increased with age and was highest in women aged 40–44 years (5.0 cases per 1000 person-years, 95% CI 4.3, 5.7 cases per 1000 person-years). Women with uterine fibroids were more likely to experience heavy or painful periods. They were also more likely to report low iron levels, endometriosis, and poor self-rated health and to have two or more annual visits to their general practitioner. LIMITATIONS, REASONS FOR CAUTION Our estimates are based on self-report of doctor diagnosis or treatment for fibroids and/or data linked to treatment and procedure administrative records. This predominantly captures women with symptomatic fibroids, but has the potential for misclassification of asymptomatic women and an underestimate of overall prevalence and incidence. In addition, questions on fibroids were only asked in surveys when women were 37–42 years of age to 43–48 years of age, so cases
doi_str_mv 10.1093/humrep/deae162
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11373412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/deae162</oup_id><sourcerecordid>3081771431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-901dd8ec23268ece6c6b8f899c3d2683da83aef9c54a92409653f3edc6c5f1263</originalsourceid><addsrcrecordid>eNqFkUFPHCEUx0lTU7e21x4bjvUwyoMZdsZLszHamph40TNh4Y2LnYURGBNvfge_oZ-k2F2NnnoC3vvx5_35E_IN2AGwThyupnXE8dCiRpD8A5lBLVnFRcM-khnjsq0AJOySzyndMFa2rfxEdkXHQEDdzEg6dTFluphSjnpw2lNM2a11xkRDT503zqI3SLW3dIx4p4d_x9KbMkbnkfZuGYOz6YhqanXWdHD-j75GasIqxExTnuw95Yyxp4dHzjj_QnZ6PST8ul33yNXpyeXx7-r84tfZ8eK8MgJYrsqM1rZouCg20KA0ctn2bdcZYUtFWN0KjX1nmlp3vGadbEQv0Bppmh64FHvk50Z3nJbrUkf_7FGNsfiL9ypop953vFup63CnAMRc1MCLwo-tQgy3U_kZtXbJ4DBoj2FKSrAW5nOoBRT0YIOaGFKK2L--A0w9R6U2UaltVOXC97fTveIv2RRgfwOEafyf2F9csaJh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3081771431</pqid></control><display><type>article</type><title>First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022</title><source>Oxford Journals Online</source><creator>Wilson, L F ; Moss, K M ; Doust, J ; Farquhar, C M ; Mishra, G D</creator><creatorcontrib>Wilson, L F ; Moss, K M ; Doust, J ; Farquhar, C M ; Mishra, G D</creatorcontrib><description>Abstract STUDY QUESTION What is the estimated prevalence and incidence of uterine fibroids diagnosed in Australian women of reproductive age? SUMMARY ANSWER An estimated 7.3% of Australian women had a diagnosis of uterine fibroids by the age of 45–49 years, with age-specific incidence highest in women aged 40–44 years (5.0 cases per 1000 person-years). WHAT IS KNOWN ALREADY Uterine fibroids are associated with a high symptom burden and may affect overall health and quality of life. Studies in different countries show a wide variation in both the prevalence (4.5–68%) and incidence (2.2–37.5 per 1000 person-years) of uterine fibroids, which may be partly explained by the type of investigation, method of case ascertainment, or the age range of the study population, necessitating the reporting of country-specific estimates. STUDY DESIGN, SIZE, DURATION This observational prospective cohort study using self-report survey and linked administrative data (2000–2022) included 8066 women, born between 1973 and 1978, in the Australian Longitudinal Study on Women’s Health. PARTICIPANTS/MATERIALS, SETTING, METHODS A combination of self-report survey and linked administrative health data (hospital, emergency department, the Medicare Benefits Schedule, and the Pharmaceutical Benefits Scheme) were used to identify women with a report of a diagnosis of uterine fibroids between 2000 and 2022. MAIN RESULTS AND THE ROLE OF CHANCE Of the 8066 Australian women followed for 22 years, an estimated 7.3% of women (95% CI 6.9, 7.6) had a diagnosis of uterine fibroids by the age of 45–49 years. The incidence increased with age and was highest in women aged 40–44 years (5.0 cases per 1000 person-years, 95% CI 4.3, 5.7 cases per 1000 person-years). Women with uterine fibroids were more likely to experience heavy or painful periods. They were also more likely to report low iron levels, endometriosis, and poor self-rated health and to have two or more annual visits to their general practitioner. LIMITATIONS, REASONS FOR CAUTION Our estimates are based on self-report of doctor diagnosis or treatment for fibroids and/or data linked to treatment and procedure administrative records. This predominantly captures women with symptomatic fibroids, but has the potential for misclassification of asymptomatic women and an underestimate of overall prevalence and incidence. In addition, questions on fibroids were only asked in surveys when women were 37–42 years of age to 43–48 years of age, so cases at younger ages may have been underestimated (particularly in women with less severe symptoms) as these were only ascertained through data linkage. WIDER IMPLICATIONS OF THE FINDINGS These are the first population-based estimates of the prevalence and incidence of uterine fibroids in women of reproductive age in Australia. Establishing these first estimates will help inform health policy and health care provision in the Australian context. STUDY FUNDING/COMPETING INTEREST(S) The ALSWH is funded by the Australian Government Department of Health and Aged Care. L.FW. was supported by an Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence grant (APP1153420) and G.D.M. was supported by an NHMRC Leadership Fellowship (APP2009577). The funding bodies played no role in the design, the collection, analysis or interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication. There are no competing interests. TRIAL REGISTRATION NUMBER N/A.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/deae162</identifier><identifier>PMID: 39013145</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Australia - epidemiology ; Cohort Studies ; Female ; Humans ; Incidence ; Information Storage and Retrieval ; Leiomyoma - epidemiology ; Longitudinal Studies ; Middle Aged ; Original ; Prevalence ; Prospective Studies ; Self Report ; Uterine Neoplasms - epidemiology ; Young Adult</subject><ispartof>Human reproduction (Oxford), 2024-09, Vol.39 (9), p.2134-2143</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-901dd8ec23268ece6c6b8f899c3d2683da83aef9c54a92409653f3edc6c5f1263</cites><orcidid>0000-0002-3685-3553 ; 0000-0001-9624-5704 ; 0000-0002-4024-9308 ; 0000-0001-8709-8968 ; 0000-0001-9610-5904</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39013145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, L F</creatorcontrib><creatorcontrib>Moss, K M</creatorcontrib><creatorcontrib>Doust, J</creatorcontrib><creatorcontrib>Farquhar, C M</creatorcontrib><creatorcontrib>Mishra, G D</creatorcontrib><title>First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022</title><title>Human reproduction (Oxford)</title><addtitle>Hum Reprod</addtitle><description>Abstract STUDY QUESTION What is the estimated prevalence and incidence of uterine fibroids diagnosed in Australian women of reproductive age? SUMMARY ANSWER An estimated 7.3% of Australian women had a diagnosis of uterine fibroids by the age of 45–49 years, with age-specific incidence highest in women aged 40–44 years (5.0 cases per 1000 person-years). WHAT IS KNOWN ALREADY Uterine fibroids are associated with a high symptom burden and may affect overall health and quality of life. Studies in different countries show a wide variation in both the prevalence (4.5–68%) and incidence (2.2–37.5 per 1000 person-years) of uterine fibroids, which may be partly explained by the type of investigation, method of case ascertainment, or the age range of the study population, necessitating the reporting of country-specific estimates. STUDY DESIGN, SIZE, DURATION This observational prospective cohort study using self-report survey and linked administrative data (2000–2022) included 8066 women, born between 1973 and 1978, in the Australian Longitudinal Study on Women’s Health. PARTICIPANTS/MATERIALS, SETTING, METHODS A combination of self-report survey and linked administrative health data (hospital, emergency department, the Medicare Benefits Schedule, and the Pharmaceutical Benefits Scheme) were used to identify women with a report of a diagnosis of uterine fibroids between 2000 and 2022. MAIN RESULTS AND THE ROLE OF CHANCE Of the 8066 Australian women followed for 22 years, an estimated 7.3% of women (95% CI 6.9, 7.6) had a diagnosis of uterine fibroids by the age of 45–49 years. The incidence increased with age and was highest in women aged 40–44 years (5.0 cases per 1000 person-years, 95% CI 4.3, 5.7 cases per 1000 person-years). Women with uterine fibroids were more likely to experience heavy or painful periods. They were also more likely to report low iron levels, endometriosis, and poor self-rated health and to have two or more annual visits to their general practitioner. LIMITATIONS, REASONS FOR CAUTION Our estimates are based on self-report of doctor diagnosis or treatment for fibroids and/or data linked to treatment and procedure administrative records. This predominantly captures women with symptomatic fibroids, but has the potential for misclassification of asymptomatic women and an underestimate of overall prevalence and incidence. In addition, questions on fibroids were only asked in surveys when women were 37–42 years of age to 43–48 years of age, so cases at younger ages may have been underestimated (particularly in women with less severe symptoms) as these were only ascertained through data linkage. WIDER IMPLICATIONS OF THE FINDINGS These are the first population-based estimates of the prevalence and incidence of uterine fibroids in women of reproductive age in Australia. Establishing these first estimates will help inform health policy and health care provision in the Australian context. STUDY FUNDING/COMPETING INTEREST(S) The ALSWH is funded by the Australian Government Department of Health and Aged Care. L.FW. was supported by an Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence grant (APP1153420) and G.D.M. was supported by an NHMRC Leadership Fellowship (APP2009577). The funding bodies played no role in the design, the collection, analysis or interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication. There are no competing interests. TRIAL REGISTRATION NUMBER N/A.</description><subject>Adult</subject><subject>Australia - epidemiology</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Information Storage and Retrieval</subject><subject>Leiomyoma - epidemiology</subject><subject>Longitudinal Studies</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Self Report</subject><subject>Uterine Neoplasms - epidemiology</subject><subject>Young Adult</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkUFPHCEUx0lTU7e21x4bjvUwyoMZdsZLszHamph40TNh4Y2LnYURGBNvfge_oZ-k2F2NnnoC3vvx5_35E_IN2AGwThyupnXE8dCiRpD8A5lBLVnFRcM-khnjsq0AJOySzyndMFa2rfxEdkXHQEDdzEg6dTFluphSjnpw2lNM2a11xkRDT503zqI3SLW3dIx4p4d_x9KbMkbnkfZuGYOz6YhqanXWdHD-j75GasIqxExTnuw95Yyxp4dHzjj_QnZ6PST8ul33yNXpyeXx7-r84tfZ8eK8MgJYrsqM1rZouCg20KA0ctn2bdcZYUtFWN0KjX1nmlp3vGadbEQv0Bppmh64FHvk50Z3nJbrUkf_7FGNsfiL9ypop953vFup63CnAMRc1MCLwo-tQgy3U_kZtXbJ4DBoj2FKSrAW5nOoBRT0YIOaGFKK2L--A0w9R6U2UaltVOXC97fTveIv2RRgfwOEafyf2F9csaJh</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Wilson, L F</creator><creator>Moss, K M</creator><creator>Doust, J</creator><creator>Farquhar, C M</creator><creator>Mishra, G D</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3685-3553</orcidid><orcidid>https://orcid.org/0000-0001-9624-5704</orcidid><orcidid>https://orcid.org/0000-0002-4024-9308</orcidid><orcidid>https://orcid.org/0000-0001-8709-8968</orcidid><orcidid>https://orcid.org/0000-0001-9610-5904</orcidid></search><sort><creationdate>20240901</creationdate><title>First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022</title><author>Wilson, L F ; Moss, K M ; Doust, J ; Farquhar, C M ; Mishra, G D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-901dd8ec23268ece6c6b8f899c3d2683da83aef9c54a92409653f3edc6c5f1263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Australia - epidemiology</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Information Storage and Retrieval</topic><topic>Leiomyoma - epidemiology</topic><topic>Longitudinal Studies</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Self Report</topic><topic>Uterine Neoplasms - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, L F</creatorcontrib><creatorcontrib>Moss, K M</creatorcontrib><creatorcontrib>Doust, J</creatorcontrib><creatorcontrib>Farquhar, C M</creatorcontrib><creatorcontrib>Mishra, G D</creatorcontrib><collection>Open Access: Oxford University Press Open Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, L F</au><au>Moss, K M</au><au>Doust, J</au><au>Farquhar, C M</au><au>Mishra, G D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022</atitle><jtitle>Human reproduction (Oxford)</jtitle><addtitle>Hum Reprod</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>39</volume><issue>9</issue><spage>2134</spage><epage>2143</epage><pages>2134-2143</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><abstract>Abstract STUDY QUESTION What is the estimated prevalence and incidence of uterine fibroids diagnosed in Australian women of reproductive age? SUMMARY ANSWER An estimated 7.3% of Australian women had a diagnosis of uterine fibroids by the age of 45–49 years, with age-specific incidence highest in women aged 40–44 years (5.0 cases per 1000 person-years). WHAT IS KNOWN ALREADY Uterine fibroids are associated with a high symptom burden and may affect overall health and quality of life. Studies in different countries show a wide variation in both the prevalence (4.5–68%) and incidence (2.2–37.5 per 1000 person-years) of uterine fibroids, which may be partly explained by the type of investigation, method of case ascertainment, or the age range of the study population, necessitating the reporting of country-specific estimates. STUDY DESIGN, SIZE, DURATION This observational prospective cohort study using self-report survey and linked administrative data (2000–2022) included 8066 women, born between 1973 and 1978, in the Australian Longitudinal Study on Women’s Health. PARTICIPANTS/MATERIALS, SETTING, METHODS A combination of self-report survey and linked administrative health data (hospital, emergency department, the Medicare Benefits Schedule, and the Pharmaceutical Benefits Scheme) were used to identify women with a report of a diagnosis of uterine fibroids between 2000 and 2022. MAIN RESULTS AND THE ROLE OF CHANCE Of the 8066 Australian women followed for 22 years, an estimated 7.3% of women (95% CI 6.9, 7.6) had a diagnosis of uterine fibroids by the age of 45–49 years. The incidence increased with age and was highest in women aged 40–44 years (5.0 cases per 1000 person-years, 95% CI 4.3, 5.7 cases per 1000 person-years). Women with uterine fibroids were more likely to experience heavy or painful periods. They were also more likely to report low iron levels, endometriosis, and poor self-rated health and to have two or more annual visits to their general practitioner. LIMITATIONS, REASONS FOR CAUTION Our estimates are based on self-report of doctor diagnosis or treatment for fibroids and/or data linked to treatment and procedure administrative records. This predominantly captures women with symptomatic fibroids, but has the potential for misclassification of asymptomatic women and an underestimate of overall prevalence and incidence. In addition, questions on fibroids were only asked in surveys when women were 37–42 years of age to 43–48 years of age, so cases at younger ages may have been underestimated (particularly in women with less severe symptoms) as these were only ascertained through data linkage. WIDER IMPLICATIONS OF THE FINDINGS These are the first population-based estimates of the prevalence and incidence of uterine fibroids in women of reproductive age in Australia. Establishing these first estimates will help inform health policy and health care provision in the Australian context. STUDY FUNDING/COMPETING INTEREST(S) The ALSWH is funded by the Australian Government Department of Health and Aged Care. L.FW. was supported by an Australian National Health and Medical Research Council (NHMRC) Centres for Research Excellence grant (APP1153420) and G.D.M. was supported by an NHMRC Leadership Fellowship (APP2009577). The funding bodies played no role in the design, the collection, analysis or interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication. There are no competing interests. TRIAL REGISTRATION NUMBER N/A.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>39013145</pmid><doi>10.1093/humrep/deae162</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3685-3553</orcidid><orcidid>https://orcid.org/0000-0001-9624-5704</orcidid><orcidid>https://orcid.org/0000-0002-4024-9308</orcidid><orcidid>https://orcid.org/0000-0001-8709-8968</orcidid><orcidid>https://orcid.org/0000-0001-9610-5904</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2024-09, Vol.39 (9), p.2134-2143
issn 0268-1161
1460-2350
1460-2350
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11373412
source Oxford Journals Online
subjects Adult
Australia - epidemiology
Cohort Studies
Female
Humans
Incidence
Information Storage and Retrieval
Leiomyoma - epidemiology
Longitudinal Studies
Middle Aged
Original
Prevalence
Prospective Studies
Self Report
Uterine Neoplasms - epidemiology
Young Adult
title First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20Australian%20estimates%20of%20incidence%20and%20prevalence%20of%20uterine%20fibroids:%20a%20data%20linkage%20cohort%20study%202000%E2%80%932022&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Wilson,%20L%20F&rft.date=2024-09-01&rft.volume=39&rft.issue=9&rft.spage=2134&rft.epage=2143&rft.pages=2134-2143&rft.issn=0268-1161&rft.eissn=1460-2350&rft_id=info:doi/10.1093/humrep/deae162&rft_dat=%3Cproquest_pubme%3E3081771431%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c310t-901dd8ec23268ece6c6b8f899c3d2683da83aef9c54a92409653f3edc6c5f1263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3081771431&rft_id=info:pmid/39013145&rft_oup_id=10.1093/humrep/deae162&rfr_iscdi=true